Sepsis and granulomatous hepatitis after bacillus Calmette-Guerin intravesical installation [1]

Journal of Infection

Volumn 48, Issue 4, 2004, Pages 363-364

  Trevenzoli, Marco ^a   Cattelan, Anna Maria ^a   Marino, Filippo ^a   Sasset, Lolita ^a   Donà, Silvio ^a   Meneghetti, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGED; BLADDER CANCER; BLOOD CULTURE; CASE REPORT; GRANULOMATOUS HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION TEST; LETTER; LIVER BIOPSY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; URINARY TRACT INFECTION; URINE CULTURE;

EID: 1942441497     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2004.01.013     Document Type: Letter

References (6)

1. Witjes JA, van der Meijden APM, Debruyne FMJ. Use of intravesical bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol Int 1990;45:129-136.
2. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RC. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986;135:272-274.
3. Lamm DL. Complications of bacillus Calmette-Guerin immunotherapy. Urol Clin North Am 1992;19:565-572.
4. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
5. DeHertogh D, Fierer E, Orell JA. Hypersensitivity reaction to bacillus Calmette-Guerin treated with plasmapheresis. Am J Med 1989;86:343-344.
6. Gonzales OY, Musher DM, Brar I, et al. Spectrum of bacillus Calmette-Guerin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis 2003;36:140-147.